ReNeuron Group plc Creditor’s decision on Administrators' Proposals

RNS Number : 2808R

ReNeuron Group plc

05 June 2024

 

5 June 2024

 

ReNeuron Group plc

("ReNeuron" or the "Company")

 

Notice of Creditor's decision on Joint Administrators' Proposals

 

Further to the announcement of the publication of the Joint Administrators' Proposals on 17 May 2024, ReNeuron Group plc (in administration) (AIM: RENE), a UK based leader in stem cell derived exosome technologies, announces that Mark Smith and Stephen Cork of Cork Gully LLP, the Joint Administrators of the Company and of its subsidiaries, ReNeuron Limited, ReNeuron (UK) Limited ReNeuron Holdings Limited (All in Administration) (together the "Group") have filed the "AM07 - Notice of creditor's decision on administrator's proposals" at Companies House. The notice will be published by Companies House in due course.

 

The notice documents that, at 23:59 hours on 30 May 2024, all decisions were duly approved by creditors.

 

Further updates on the administration process will be made when appropriate

Enquiries:

 

Cork Gully LLP	[phone] or
Stephen Cork, Joint Administrator	[e-mail]
Mark Smith, Joint Administrator
ReNeuron	www.reneuron.com/investors
Iain Ross, Executive Chairman	Via Walbrook PR
Allenby Capital Limited (Nominated Adviser and Broker)			[phone]
James Reeve/George Payne/Dan Dearden-Williams (Corporate Finance)
Stefano Aquilino/Kelly Gardiner (Sales & Corporate Broking)
Walbrook PR (Media & Investor Relations)		[phone] or [e-mail]
Paul McManus / Alice Woodings	[phone] / [phone]

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

MSCBSGDLUXGDGSU